logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Mitsui & Co., Ltd. and ROHTO to jointly acquire Eu Yan Sang International Ltd in a strategic move for wellness ecosystem creation.

Apr 05, 2024•over 1 year ago

Acquiring Company

Mitsui & Ltd

Acquired Company

Eu Yan Sang International Ltd

ChiyodaOsakaSingaporeInvestment ManagementPharmaceutical ManufacturingFitnessWellnessHealth Care

Description

Mitsui & Co., Ltd. has made a strategic decision to jointly acquire shares in Eu Yan Sang International Ltd with ROHTO Pharmaceutical Co., Ltd. This acquisition is part of Mitsui's goal to create a wellness ecosystem by providing healthcare, preventive care, solutions for pre-symptomatic conditions, and foods that offer health benefits. The acquisition will leverage the competitiveness of Eu Yan Sang's brand and products in Asia and ROHTO's R&D and marketing capabilities to create an innovative new business in the wellness industry.

Company Information

Company

Mitsui & Ltd

Location

Chiyoda, Tokyo, Japan

About

Mitsui & Co., Ltd. is a global trading and investment company with a diverse business portfolio that spans various industry sectors, including Energy, Metals, Machinery, Chemicals, Food, and Consumer Services. It is committed to creating innovative businesses and value by leveraging its integrated corporate strength and global network.

Company

ROHTO Pharmaceutical Co., Ltd.

Location

Osaka, Osaka Prefecture, Japan

About

ROHTO Pharmaceutical Co., Ltd is a multinational company with a history of over 120 years, renowned for its fast-moving consumer goods and OTC drugs. Headquartered in Osaka, Japan, with various domestic and overseas subsidiaries. Although we were initially known for OTC drugs, part of our DNA is to do the unexpected, and for the purpose of people and society’s well-being, we pursue businesses not limited to pharmaceutical operations. Our devotion to meet and exceed customer expectations is the core of Rohto’s business, which has been our main motivator and guidance throughout these years. Recently we announced our comprehensive Management Vision 2030, establishing the core areas we want to strengthen by 2030. With our spirit of "NEVER SAY NEVER" we strive to make every individual and society healthier.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed